Literature DB >> 12095175

Synthesis of factor D by gastric cancer-derived cell lines.

Etsuko Kitano1, Hajime Kitamura.   

Abstract

Synthesis of complement components in vitro by four human gastric cancer-derived cell lines, MKN28, MKN74, MKN45 and KATO-III, was studied. When these cells were cultured for 3 days without addition of any stimulator, 0.94 +/- 0.49, 2.10 +/- 0.59, 7.29 +/- 5.94 and 2.47+/- 1.34 ng of factor D/10(6) cells were detected in supernatants of MKN28, MKN74, MKN45 and KATO-III, respectively. Factor D production by these cells was reversibly inhibited by the presence of cycloheximide. Factors B, C3 and C2 were also detected in protein-free culture medium of these cell lines. Addition of tumour necrosis factor (TNF) to culture enhanced C3 and factor B secretion but depressed C2 secretion, without any distinct effect on factor D secretion. Since all cell lines tested secreted significant amounts of factor D without addition of any stimulator in medium, it is possible that factor D may be synthesized by gastric epithelial cells physiologically and constitutively. From a quantitative analysis of factor D secretion by these cells, factor D secreted by gastric tissue is likely to contribute to the factor D level in circulating blood. The possible mechanism of participation of complement system in inflammation of gastric epithelium was proposed. Thus, the present study may be significant for clarification of the mode of extrahepatic complement synthesis participating in mucosal immunity.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12095175     DOI: 10.1016/s1567-5769(02)00028-0

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  5 in total

1.  Computational prediction of human proteins that can be secreted into the bloodstream.

Authors:  Juan Cui; Qi Liu; David Puett; Ying Xu
Journal:  Bioinformatics       Date:  2008-08-12       Impact factor: 6.937

2.  Complement gene expression in human cardiac allograft biopsies as a correlate of histologic grade of injury.

Authors:  Karen Keslar; E Rene Rodriguez; Carmela D Tan; Randall C Starling; Peter S Heeger
Journal:  Transplantation       Date:  2008-11-15       Impact factor: 4.939

3.  Gene expression signature analysis identifies vorinostat as a candidate therapy for gastric cancer.

Authors:  Sofie Claerhout; Jae Yun Lim; Woonyoung Choi; Yun-Yong Park; Kyounghyun Kim; Sang-Bae Kim; Ju-Seog Lee; Gordon B Mills; Jae Yong Cho
Journal:  PLoS One       Date:  2011-09-09       Impact factor: 3.240

Review 4.  Targeting the Complement Pathway in Malignant Glioma Microenvironments.

Authors:  Hongtao Zhu; Xingjiang Yu; Suojun Zhang; Kai Shu
Journal:  Front Cell Dev Biol       Date:  2021-04-01

5.  Complement Factor D Is a Novel Biomarker and Putative Therapeutic Target in Cutaneous Squamous Cell Carcinoma.

Authors:  Pegah Rahmati Nezhad; Pilvi Riihilä; Jaakko S Knuutila; Kristina Viiklepp; Sirkku Peltonen; Markku Kallajoki; Seppo Meri; Liisa Nissinen; Veli-Matti Kähäri
Journal:  Cancers (Basel)       Date:  2022-01-08       Impact factor: 6.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.